• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Unlocking the mysteries of memory — and potentially enhancing it

Bioengineer by Bioengineer
September 27, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Memory acts like an anchor, reminding us of past experiences that have made us who we are today. Attempts to boost it, particularly as we age, have sprouted cottage industries of supplements and brain games. In parallel, researchers have been pursuing pharmaceutical interventions. In some of the latest work on this front, one team reports in ACS Chemical Neuroscience that they have identified a novel compound that enhances long-term memory in animal studies.

In the past two decades, scientists have discovered key molecular paths that can lead to the formation of long-term memories in fruit flies, mice and rats. For example, the activation of a particular protein called CREB — which stands for "cAMP response element binding" — is required to stow memories for the long term. Building on this finding, Alan P. Kaplan and colleagues have been working to find compounds that help spur CREB into action.

The researchers screened thousands of small molecules for potential drug candidates that activate CREB and found a compound called HT-0411 that was promising. Further testing showed that HT-0411 doesn't directly activate CREB. It does so indirectly by inhibiting the enzyme monoamine oxidase B, which modulates dopamine and ultimately leads to CREB-mediated gene expression. The researchers then tweaked parts of that compound's structure and administered it to mice and rats. In memory tests, the animals that received the candidate molecule scored much higher than the control group, and they showed no signs of behavioral side effects such as changes in anxiety levels.

###

The authors acknowledge funding from Dart NeuroScience LLC.

The abstract that accompanies this study is available here.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us on Twitter | Facebook

Media Contact

Katie Cottingham
[email protected]
301-775-8455
@ACSpressroom

http://www.acs.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Selenium-Enriched Yeast Offers a Powerful Antioxidant Shield for Stressed Pigs

Selenium-Enriched Yeast Offers a Powerful Antioxidant Shield for Stressed Pigs

September 11, 2026
Sangsang yak genome reveals distinct evolutionary path from other yaks

Sangsang yak genome reveals distinct evolutionary path from other yaks

September 11, 2026

A total infectome framework for resolving complex disease etiology in aquaculture

September 11, 2026

VALD-3 Triggers Pyroptosis in Triple-Negative Breast Cancer Through ROS/JNK/Bax Pathway

September 11, 2026
Please login to join discussion

POPULAR NEWS

  • Glucose-Lowering Drugs and Brain Health: Mechanisms, Evidence, and Future Directions

    29 shares
    Share 12 Tweet 7
  • Advanced cancer patients face distress and conflict when consenting to treatment

    29 shares
    Share 12 Tweet 7
  • Barriers, facilitators, and motives for medical research in a developing country

    29 shares
    Share 12 Tweet 7
  • Single-marker method quantifies seven glycosides in prepared Rehmannia root

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Glucose-Lowering Drugs and Brain Health: Mechanisms, Evidence, and Future Directions

Advanced cancer patients face distress and conflict when consenting to treatment

Barriers, facilitators, and motives for medical research in a developing country

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.